1. Home
  2. IMUX vs WIMI Comparison

IMUX vs WIMI Comparison

Compare IMUX & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMUX
  • WIMI
  • Stock Information
  • Founded
  • IMUX 2016
  • WIMI 2015
  • Country
  • IMUX United States
  • WIMI China
  • Employees
  • IMUX N/A
  • WIMI N/A
  • Industry
  • IMUX Biotechnology: Pharmaceutical Preparations
  • WIMI Computer Software: Prepackaged Software
  • Sector
  • IMUX Health Care
  • WIMI Technology
  • Exchange
  • IMUX Nasdaq
  • WIMI Nasdaq
  • Market Cap
  • IMUX 86.3M
  • WIMI 94.3M
  • IPO Year
  • IMUX N/A
  • WIMI 2020
  • Fundamental
  • Price
  • IMUX $1.05
  • WIMI $0.99
  • Analyst Decision
  • IMUX Strong Buy
  • WIMI
  • Analyst Count
  • IMUX 6
  • WIMI 0
  • Target Price
  • IMUX $12.67
  • WIMI N/A
  • AVG Volume (30 Days)
  • IMUX 657.3K
  • WIMI 4.1M
  • Earning Date
  • IMUX 02-24-2025
  • WIMI 01-01-0001
  • Dividend Yield
  • IMUX N/A
  • WIMI N/A
  • EPS Growth
  • IMUX N/A
  • WIMI N/A
  • EPS
  • IMUX N/A
  • WIMI N/A
  • Revenue
  • IMUX N/A
  • WIMI $84,137,968.00
  • Revenue This Year
  • IMUX N/A
  • WIMI N/A
  • Revenue Next Year
  • IMUX N/A
  • WIMI N/A
  • P/E Ratio
  • IMUX N/A
  • WIMI N/A
  • Revenue Growth
  • IMUX N/A
  • WIMI 19.25
  • 52 Week Low
  • IMUX $0.92
  • WIMI $0.63
  • 52 Week High
  • IMUX $2.11
  • WIMI $2.92
  • Technical
  • Relative Strength Index (RSI)
  • IMUX 55.70
  • WIMI 48.24
  • Support Level
  • IMUX $0.92
  • WIMI $0.86
  • Resistance Level
  • IMUX $1.15
  • WIMI $1.08
  • Average True Range (ATR)
  • IMUX 0.06
  • WIMI 0.07
  • MACD
  • IMUX 0.01
  • WIMI 0.02
  • Stochastic Oscillator
  • IMUX 56.52
  • WIMI 62.48

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

About WIMI WiMi Hologram Cloud Inc.

WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings primarily consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.

Share on Social Networks: